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Ionotropic GABA receptors (GABAA and GABAC) belong to the Cys-loop receptor family of ligand-gated ion channels. GABAC receptors
are highly expressed in the retina, mainly localized at the axon terminals of bipolar cells. Ascorbic acid, an endogenous redox agent,
modulates the functionof diverse proteins, andbasal levels of ascorbic acid in the retina are veryhigh.However, the effect of ascorbic acid
on retinal GABA receptors has not been studied. Here we show that the function of GABAC and GABAA receptors is regulated by ascorbic
acid. Patch-clamp recordings from bipolar cell terminals in goldfish retinal slices revealed that GABAC receptor-mediated currents
activated by tonic background levels of extracellular GABA, and GABAC currents elicited by local GABA puffs, are both significantly
enhancedbyascorbic acid. In addition, a significant rundownofGABApuff-evoked currentswasobserved in the absenceof ascorbic acid.
GABA-evoked Cl currents mediated by homomeric 1 GABAC receptors expressed in Xenopus laevis oocytes were also potentiated by
ascorbic acid in a concentration-dependent, stereo-specific, reversible, and voltage-independentmanner. Studies involving the chemical
modification of sulfhydryl groups showed that the two Cys-loop cysteines and histidine 141, all located in the 1 subunit extracellular
domain, each play a key role in themodulation of GABAC receptors by ascorbic acid. Additionally, we show that retinal GABAA IPSCs and
heterologously expressed GABAA receptor currents are similarly augmented by ascorbic acid. Our results suggest that ascorbic acidmay
act as an endogenous agent capable of potentiating GABAergic neurotransmission in the CNS.
Introduction
The ionotropicGABA receptors,members of theCys-loop recep-
tor family, are GABA-gated pentameric chloride (Cl) channels
(Moss and Smart, 2001; Zhang et al., 2001). They are usually
divided into two classes, namely, GABAA and GABAC receptors.
GABAC receptors are composed of rho subunits, which are highly
expressed in retinal bipolar cells (Wa¨ssle et al., 1998;McCall et al.,
2002). They play an important role in the control of axon termi-
nal excitability by mediating reciprocal synapses with amacrine
cells (Matthews et al., 1994; Dong and Werblin, 1998; Protti and
Llano, 1998;Hartveit, 1999).GABAC receptors alsomediate tonic
inhibitory currents, which arise in response to extracellular
GABA concentrations controlled locally by GABA transporter 1
(GAT-1) transporters located on amacrine cells (Hull et al., 2006;
Jones and Palmer, 2009). Unlike GABAA receptors, GABAC re-
ceptors display both high affinity for GABA and a lack of desen-
sitization (Johnston, 1996). These two properties allow them to
mediate several modes of inhibitory signaling in the retina
(Zhang and Slaughter, 1995; Lukasiewicz et al., 2004), including
inhibition of vesicle recycling (Hull and von Gersdorff, 2004).
Ascorbic acid (vitamin C), an endogenous redox agent highly
concentrated in the retina and other regions of the CNS, is accu-
mulated in neurons and glial cells by specific transporters (Rebec
and Pierce, 1994; Rice, 2000; Harrison and May, 2009). In the
retina, ascorbic acid levels rise above 100 times the concentration
found in blood plasma (Rose and Bode, 1991; Hediger, 2002).
Interestingly, the extracellular concentration of ascorbic acid can
transiently undergo substantial increases during neuronal activ-
ity (Bigelow et al., 1984; Gru¨newald, 1993). In retinal neurons,
the ascorbate transporter SVCT2 (sodium-dependent vitamin C
transporter 2) mediates extensive sodium-dependent ascorbic
acid extrusion through a mechanism regulated by neuronal de-
polarization and glutamate concentration (Portugal et al., 2009).
In addition, ascorbic acid has been shown to modulate the activ-
ity of NMDA glutamate receptors and voltage-activated ion
channels (Majewska et al., 1990; Fan and Yazulla, 1999; Alshuaib
andMathew, 2006;Nelson et al., 2007). Remarkably, its effects on
Cys-loop receptors have not been previously studied in the retina.
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We analyzed here whether GABAC receptor function can be
regulated by ascorbic acid. GABAC receptor-mediated currents
were measured frommixed rod-cone ON-type (Mb) bipolar cell
terminals in goldfish retinal slices and from Xenopus laevis
oocytes expressing recombinant homomeric 1 GABAC recep-
tors.We show that the function of native retinal and recombinant
GABAC receptors is significantly enhanced in the presence of
ascorbic acid. Experiments involving the chemical modification
of sulfhydryl groups and site-directed mutagenesis of the 1 sub-
unit indicate that cysteines 177 and 191 forming theCys-loop and
histidine 141 (H141), all located in the N-terminal extracellular
domain, are critical for the modulation of GABAC receptors by
ascorbic acid. Additionally, we found that GABAA receptor-
mediated miniature IPSCs (mIPSCs) at Mb retinal bipolar cell ter-
minals, and ionic currents mediated by GABAA receptors
heterologously expressed inHEK293 cells, are potentiated by ascor-
bic acid. Together, our results suggest that ascorbic acid can be a
powerful endogenousmodulator ofGABAergic neurotransmission.
Materials andMethods
Retinal slice preparation and electrophysiology. Retinal slices were pre-
pared from pieces of retina, taken from goldfish (Carassius auratus; 8–16
cm) of either sex, according to procedures described previously (Palmer
et al., 2003). The slices (250 m thick) were constantly perfused at 4–5
ml/min with 2.5 mM Ca2 Ringer’s solution for patch-clamp recording.
Bipolar cell terminalswith severedaxons (axotomized)were identified in the
inner plexiform layer based on (1) single-exponential membrane time con-
stant, (2) the presence of an L-type Ca2 current and Cm jump, and (3)
Mb-shaped (bulbous) terminal morphology (Palmer et al., 2003).
Axotomized bipolar cell terminals in retinal slices were voltage-
clamped in thewhole-cellmode using anHEKAElektronik EPC-9 patch-
clamp amplifier in conjunction with Pulse software running the xChart
extension (Pulse version 8.53). The SineDC technique was used for
real-time measurements of membrane capacitance. Briefly, a 30 mV
peak-to-peak 1 kHz sine wave was superimposed on the holding poten-
tial of the cells (60 mV) and was used by on-line analysis software to
calculate time-resolved membrane capacitance. Standard external re-
cording solutions contained the following (in mM): 100 NaCl, 2.5 KCl,
2.5 CaCl2, 1.0 MgCl2, 25 NaHCO3, and 12 glucose, pH 7.45 (osmolarity,
260–265mOsm). In some cases, 3mM ascorbic acidwas added to record-
ing solutions, which were then rebubbled with 95%O2/5%CO2. In these
cases, pH and osmolarity were readjusted following bubbling. Patch pi-
pettes (6–8M) were pulled fromborosilicate capillary glass and coated
with dental wax to reduce pipette capacitance. Internal pipette solutions
contained the following solutions (in mM): 60 Cs gluconate, 40 CsCl, 10
TEA-Cl, 25HEPES, 3Mg-ATP, 0.5 Na-GTP, and 2 EGTA. Some internal
solutions contained 3 mM ascorbic acid. All internals were set to pH 7.2
with CsOH, and osmolarity was adjusted to 250 mOsm. DL-APV, NBQX,
TPMPA [(1,2,5,6-tetrahydropyridin-4-yl)methylphosphinic acid], and
SR95531 (gabazine) were obtained fromTocris Bioscience. All other chem-
icals were obtained from Sigma.
For puff applications, GABA was dissolved in Ringer’s solution along
with, in some cases, 3 mM ascorbic acid and/or 25 M SR95531. The pH
was corrected to 7.45, and osmolarity was adjusted to 260 mOsm. This
solutionwas then loaded in a patch pipette (see above) and puffed at 5 psi
for 25 ms onto the axotomizedMb terminal at a distance of10–30 M
using a Picospritzer III (Parker Instrumentation) driven by 100%N2 gas.
Miniature GABAA currents (mIPSCs) were measured in recording solu-
tion containing 150 M TPMPA, 1 M TTX, 10 M NBQX, and 50 M
DL-APV. The holding potential was60mV, and data were acquired in a
series of successive 60 s sweeps in continuous recording mode. mIPSCs
were analyzed using a custom Igor procedure that used template match-
ing and thresholding techniques. In some cases, noise distributions were
determined by analysis of sweeps following addition of 25 M SR95531.
Standing GABAC leak current was measured using the Pulse xChart ex-
tension (16Hz acquisition rate, up to 50 point averaging) in the presence
of 25 M SR95531. Holding potential was set at60 mV, and the mini-
mum period for determination of stable leak current, as determined by
recording chamber volume replacement rate, was 18 s.
Statistical analyses were performed using Prism (version 4; GraphPad
Software) with one-way repeated-measures ANOVA, Dunnett’s or
Tukey’s post hoc tests, and two-tailed unpaired or paired Student’s t tests
for comparing datasets. One-sample t tests were used to compare nor-
malized data to a theoretical mean of zero. F tests were used to compare
fitted slopes from linear regression either with a theoretical value of zero
or between datasets. Data are reported as mean  SEM. Statistics were
performed on averaged traces where noted. mIPSC analysis was per-
formed with Igor Pro v.5.04b (WaveMetrics).
RNA preparation, oocyte isolation, injection, and electrophysiology. A
human cDNA encoding the 1 GABAC receptor subunit cloned in the
vector suitable for in vitro transcription pGEMwas used as a template to
synthesize cRNAs in vitro (mMessage mMachine kit, Ambion). Site-
directedmutagenesis was achieved by the PCRoverlap extensionmethod
using QuickChange Site-Directed Mutagenesis Kit (Stratagene). cRNA
solutions (0.1–0.3 ng/nl) were prepared in RNase-freeH2O and stored at
70°C. Oocytes, at stages V and VI, were used for expression of exoge-
nous cRNAs. Isolation and maintenance of cells were performed as pre-
viously described (Miledi et al., 1989). Briefly, female X. laevis frogs
(Nasco)were anesthetizedwith 3-aminobenzoic-acid ethylester (1mg/
ml), and ovaries were surgically removed. Ovaries were incubated with
200 U/ml type I or type II collagenase (Worthington) for 30min at room
temperature (RT) and isolated oocytes maintained in an incubator at
17°C in Barth’s medium as follows (in mM): 88 NaCl; 0.33 Ca(NO3)2;
0.41 CaCl2; 1 KCl; 0.82 MgSO4; 2.4 NaHCO3; 10 HEPES and 0.1 mg/ml
gentamicin; pH 7.4. After 1 d, each oocyte was manually microinjected
(microinjectorDrummond Scientific) with 50 nl of a solution containing
50 ng of cRNA. Two-electrode voltage-clamp recordingswere performed
3–7 d after oocyte injection with an Axoclamp 2B amplifier (Molecular
Devices). Standard glass recording electrodes weremade in a PB-7 puller
(Narishige Scientific Instrument Laboratory) and filled with 3 M KCl.
Pipette resistance values were1 M. The holding potential was set to
70 mV, and current traces were acquired in a PC through Labmaster
TL-1 DMA interface (Scientific Solutions) using pClamp software (Mo-
lecular Devices). Cells were placed in a chamber (volume 100l) contin-
uously superfused (12mlmin1) with frogRinger’s solution (inmM: 115
NaCl; 2 KCl; 1.8 CaCl2; 5 HEPES; pH 7.0). Drugs were applied through
the perfusion system, and all the experiments were performed at RT
(23–24°C). The agonist and all the drug and salts, HEPES, ascorbate
analogs, 3-aminobenzoic-acid ethylester, and RNase-free H2O, were
purchased from Sigma-Aldrich. Ascorbic acid, L-dehydroascorbic acid
(DHA), calcium ascorbate [Ca(Asc)2], and D-isoascorbic acid (D-iso Asc)
solutions were prepared freshly each day in normal Ringer’s solution,
and the pH was always adjusted to 7.0 with NaOH (1 M). Data were
analyzed with Prism v. 6.0 (MicroCal). Statistical analysis was performed
using one-way ANOVA and Tukey’s or Dunnett’s test. Dose–response
curves (D–R) forGABAwere fit with the expression of thementioned logis-
tic equation: Imax B{1 1/[1 (A/EC50)
n]}, where A is the agonist con-
centration, B is the maximal response, EC50 is the concentration of agonist
that elicits half-maximal responses, and n is the Hill coefficient.
Cell culture, transfection, and electrophysiology.HEK293 cells were cul-
tured using standardmethodologies (Yevenes et al., 2006). Transfections
were performed using Lipofectamine 2000 (Invitrogen) with 2 g of
DNA for each plasmid studied per well. cDNA constructs encoding the
1, 2, and 2 rat GABAA was subcloned in the pRK5 vector (BD
Pharmingen). Whole-cell recordings, at a holding potential of60 mV,
were performed as previously described 18–36 h after transfection. Patch
electrodes were filled with the following (in mM): 140 CsCl, 10 1,2-bis-
(2-aminophenoxy)-ethane-N,N,N=,N=-tetraacetic acid, 10 HEPES, pH
7.4, 4 MgCl2, 2 ATP, and 0.5 GTP. The external solution contained the
following (in mM): 150 NaCl, 10 KCl, 2.0 CaCl2, 1.0 MgCl2, 10 HEPES,
pH 7.4, and 10 glucose. The amplitude of the GABA current was assayed
using a short (1–2 s) pulse of 30–40 M GABA every 60 s. Bicuculline (1
M) blocked all of the current mediated by GABAA receptors (data not
shown). GABA was unable to produce any response in 50 nontrans-
fected cells. Statistical analyses were performed using ANOVA, and re-
sults were expressed as the arithmetic means  SE; values of p 	 0.05
Calero et al. • GABA Receptors and Vitamin C J. Neurosci., June 29, 2011 • 31(26):9672–9682 • 9673
were considered statistically significant. For all
of the statistical analysis and plots, Origin 6.0
(MicroCal) software was used.
Results
GABAC currents inMb retinal bipolar
cell terminals are enhanced by
ascorbic acid
Previous work has shown that both
GABAA and GABAC receptors mediate
chloride currents at Mb bipolar cell pre-
synaptic terminals in goldfish retinal slices
(Vigh and von Gersdorff, 2005). GABAC
receptors at the bipolar cell terminals me-
diate a tonic current, which is activated by
background levels of extracellular GABA.
This current corresponds to a standing
leak current sensitive to the selective
GABAC receptor antagonist TPMPA and
resistant to the GABAA receptor antago-
nist bicuculline-methiodide and SR-
95531. Here we studied the effects of
ascorbic acid on GABAC receptor-
mediated responses using patch-clamp
recording from axotomized Mb bipolar
cell presynaptic terminals in the presence of
25MSR-95531 toblockGABAAresponses.
Figure 1A, left, illustrates a representative
trace showing the effects of ascorbic acid on
a GABAC tonic current recorded at 60
mV. Overall, the GABAC-mediated stand-
ing leak current was significantly enhanced
by bath application of 3mMascorbic acid [0
mM Asc49.17 6.72 pA; 3 mM Asc
61.44  7.64 pA; wash (0 mM Asc) 
48.66 6.80 pA, n 11; repeated-mea-
suresANOVA,p	0.01;Dunnett’smultiple
comparison test, p	 0.01; paired t test, p
0.0053). During washout, the leak current
was significantly reduced to nearly baseline
levels (Fig. 1A, right, summary data) (Dun-
nett’s test, p	 0.01; paired t test, p	 0.001).
Normalized measures of enhancement of
leak current and washout were also signifi-
cant (3 mM Asc  30.43  9.61%; 0 mM
Asc 0.24 5.54%; one-sample t test, hy-
pothetical value 0; 3 mM Asc: p	 0.05; 0
mMAsc:p0.01). Similarhighly significant
enhancement [0mMAsc235.357.65
pA; 3 mM Asc302.4 55.79 pA; wash
(0 mM Asc)272.70 45.40 pA; n 4;
repeated-measures ANOVA, p 	 0.01;
Dunnett’s test, p 	 0.01; paired t test, p 
0.0073] of leak current by ascorbic acid
was obtained when the GABAC tonic cur-
rent was recorded in the presence of the
GAT-1 selective blocker NO-711 [example trace: 3 M NO-711
(Fig. 1B, left); summary data: 1 or 3 M NO-711, n  1,3, data
collapsed (Fig. 1B, right)], which increased the basal extracellular
GABAconcentration by inhibitingGABAuptake.Washout of the
effect of ascorbic was not significant in the presence of NO-711
(paired t test, p  0.058) (Fig. 1B, right), which may be due to
increased variability of extracellular GABA concentration and
difficulty establishing stable baseline leak current in the absence
of functioning GAT-1 transporters (Hull et al., 2006). Normal-
ized changes in leak current in the presence of NO-711 also re-
vealed significant ascorbic acid-mediated enhancement of leak
current (3 mM Asc  33.63  8.78%; 0 mM Asc  21.97 
8.97%; one-sample t test, hypothetical value 0, 3 mM Asc: p	
0.05; 0 mMAsc: p 0.05). Bath application of 300MTPMPA in
the presence of 25 M SR-95531 (Fig. 1C, left, example trace)
Figure 1. Ascorbic acid reversibly enhances GABAC-mediated standing leak current in axotomized Mb bipolar cell presynaptic
terminals. A, GABAC leak current is enhanced by bath application of Asc. Whole-cell voltage-clamp recording of anMb terminal in
the presence of 25 M SR-95531 shows a GABAC-mediated leak current of52.5 pA at60 mV (left). The leak current was
enhanced by 8 pA following bath application of 3mM ascorbic acid. Duringwash (0mMAsc), the leak currentwas reduced nearly to
its original level. Ascorbic acid significantly and reversibly enhanced GABAC-mediated leak current in the absence of NO-711 (n
11; right). Themean for all cellswith SE is shown in dark gray (circles) and is connected by a solid line; data fromeach single cell are
shown in light gray (“x”) and are connected by a dashed line. B, Whole-cell voltage-clamp recording of an Mb terminal in the
presence of 25M SR-95531 and 3M NO-711 shows a GABAC-mediated leak current of400.6 pA at60 mV (left). The leak
currentwas enhancedby 55pA followingbath application of 3mMAsc. Duringwash (0mMAsc, 3MNO-711), the leak currentwas
reduced to its original level. Ascorbic acid significantly enhanced GABAC-mediated leak current in the presence of 1–3M NO-711
(n 4; right). Washout was nearly significant. C, Standing leak current consists of both TPMPA-sensitive and TPMPA-insensitive
components. Whole-cell recording (left) of an axotomized Mb1 terminal voltage-clamped at60 mV shows a leak current of
34.7 pA that is stably reduced to16.4 pAby bath application of 300M TPMPA in the presence of 0mMascorbic acid. Addition
of 300M TPMPA in the presence of 25M SR95531 and 0 mM ascorbic acid produced a statistically significant reduction in leak
current (n 4; right). *p	 0.05; **p	 0.01; ***p	 0.001; n.s., p 0.05; all statistical tests reflect a repeated-measures
design; all errors are expressed asSE, unless otherwise noted.
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significantly reduced leak current (control: 31.5  3.8 pA;
TPMPA: 14.2 3.0 pA; n 4, paired t test, p 0.015) (Fig. 1C,
right) in axotomized Mb terminals, indicating the presence of a
small, non-GABAC-mediated leak current. Subtraction of this
non-GABAC leak current from recordings in the absence or pres-
ence of NO-711 yielded estimated ascorbic acid potentiation of
pure GABAC leak current of65.0 30.2% and36.5 9.9%,
respectively. This is consistent with enhanced ascorbic acid-
mediated potentiation of GABAC currents at low GABA
concentrations.
We also evoked GABAC responses by GABA pressure ejecting
(puffing) GABA directly onto presynaptic terminals of bipolar
cells (Fig. 2A) [25 ms puff, 30 s interstimulus interval (ISI)]. The
amplitude of GABAC current responses to puff application of
GABA exhibited significant rundown (30%) over 15min in the
absence of ascorbic acid [example: Fig. 2A left, summary data; B,
0mMAsc rundown linear regression,2.31 0.08%perminute;
slope significantly nonzero (p 	 0.0001)]. Perfusion solution
contained 25 M SR-95531 in all cases. Some experiments were
performed with 25 M SR-95531 in the puff pipette, but showed
no change in rundownkinetics (data not shown). Including 3mM
ascorbic acid in the bath solution, intracellular solution, and puff
pipette significantly slowed and/or blocked this rundown over
the same time period [example: Fig. 2A, right; B, 3 mM Asc linear
regression: 0.16  0.11% per minute; slope not significantly
nonzero (p  0.05)]. This effect on rundown slope was highly
significant (Fig. 2B) [F 28.7, degrees of freedom for numerator
variance (DFn)  1; degrees of freedom for denominator vari-
ance (DFd)  306; p 	 0.0001]. The two conditions were com-
pared at individual time points, revealing significant block of
GABAC current rundown by 3 mM ascorbic acid (in the puff
pipette, patch pipette, and perfusion solution) at 5min (unpaired
t test, n  7,7; p  0.0036) and 10 min (p  0.0031), but not at
14.5min (p 0.0936). Addition of 3mM ascorbic acid to the bath
solution alone appeared to slow rundown during the first 5 min
of puff application, but this effect did not reach significance over
the entire 15 min period (data not shown). Summary data were
collapsed across conditions where either 200M (n 4) or 1mM
GABA (n 3) was used for puff application, as analysis showed
no difference in rundown slope between these conditions from 0
to 15min (n 4, 3; F 0.40; DFn 1; DFd 112; p 0.53; data
not shown).
We also quantified the amplitude of GABAC responses to puff
application of GABA before (control), during, and after (wash)
bath application of 3 mM ascorbic acid (Fig. 3A,B). Puff applica-
tions of GABA, collapsed across 1 mM (n 7) and 200 M (n
1), produced large TPMPA-sensitive (data not shown) GABAC
receptor-mediated inward currents at60 mV (Fig. 3A). Ascor-
bic acid application significantly and reversibly [0 mM Asc 
661.2  176.0 pA; 3 mM Asc  729.8  174.9 pA; wash (0 mM
Asc)  579.7  153.8 pA; repeated-measures ANOVA (n  8,
p 0.01); Tukey’s multiple comparison test (0 mM Asc vs 3 mM
Asc: p	 0.05; 3mMAsc vsWash (0mMAsc): p	 0.05)] increased
GABAC puff response amplitude by 16% (Fig. 3A, bottom).
Analysis of responses normalized to control amplitudes also
showed a significant increase in 3 mM ascorbic acid (16.29 
5.37%; one-sample t test, p  0.019), while normalized ampli-
tudes during washout were not significantly nonzero (9.11 
6.98%, one-sample t test, p  0.233). Correction of averaged
traces forGABAC rundown (based on linear regressions shown in
Fig. 2), revealed a large effect of ascorbic acid that was nearly
reversible during washout (Fig. 3B, bottom). Potentiation of
GABAC-mediated responses to puff application of GABA was
highly significant following correction for rundown, although
this potentiation was not significantly reversed during washout
(Fig. 3B, bottom) [0 mM Asc  675.5  178.3 pA; 3 mM Asc 
826.6  198.0 pA; wash (0 mM Asc)  746.8  196.1 pA;
repeated-measures ANOVA (n 8, p 0.01); Tukey’s multiple
comparison test (0 mM Asc vs 3 mM Asc: p 	 0.01, 3 mM Asc vs
Wash: p  0.05)]. The lack of significant washout for corrected
data is probably due to increased variability in rundown for data
acquired10 min after break-in (Fig. 2B). Analysis of corrected
responses normalized to control amplitudes showed a highly sig-
nificant increase in 3 mM ascorbic acid (28.29  6.73%; one-
Figure 2. Rundown of GABAC-mediated responses to puff application of GABA in axoto-
mized Mb bipolar cell presynaptic terminals is significantly slowed and/or prevented by the
presence of intracellular and extracellular ascorbic acid. A, Puff application of GABA (25 ms
duration, indicated by black bar) was performed every 30 s for 15 min to assess the degree of
rundown of the resulting GABAC-mediated currents. Perfusion solution contained 25 M SR-
95531 (a GABAA antagonist) in all cases. Some experiments were performed with 25M SR-
95531 in the puff pipette, with no change in rundown kinetics (data not shown). An individual
example of GABAC current rundown shows that, in the absence of ascorbic acid either in the puff
pipette, patch-clamp pipette, or perfusion solution, 25 ms puff application of 200 M GABA
with a 30 s (ISI) resulted in a 27.3% rundown in current amplitude over 14.5 min (left). Right,
Same as left, except that in this example 3 mM ascorbic acid was included in the puff pipette,
patch-clamp pipette, and perfusion solution. Under these conditions, rundown of GABAC cur-
rent amplitudeover 14.5minwas8.7%.Over the first 5min,GABAC current amplitude increased
by 3.7%. B, The GABA puff experiments from A were repeated in the presence (n 7) or
absence (n 7) of 3mM ascorbic acid in the puff pipette, patch pipette, and perfusion solution,
with 25M SR-95531 in the perfusion solution (and, in some cases, in the puff pipette). Shown
are the mean normalized GABAC current amplitudes for each 30 s interval at which GABA was
puff applied for 25 ms. Error bars indicate mean SEM. The slope of rundown for each condi-
tion was fit with linear regression (solid lines). Dashed lines indicate 95% confidence interval
boundaries for each condition. The effect of ascorbic acid on rundownwas highly significant at
5 and 10 min. **p	 0.01; all errors expressed asSE, unless otherwise noted.
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sample t test, p  0.004), while normalized amplitudes during
washout were not significantly nonzero (14.18  9.17%; one-
sample t test, p 0.166). It is worth noting that, even though we
know the exact concentration of GABA inside the pipette, it is
difficult to quantitatively control the local concentration of
GABA at bipolar terminal presynaptic receptors due to effects
of transporters and extracellular diffusion. Thus, low concen-
trations of GABA applied to the bath or locally puff applied
often do not produce a robust, stable response. Despite these
issues, a significant dose dependency of ascorbic acid-mediated po-
tentiation on the concentration of puffed GABA was observed
between 1 and 10 mM (1 mM GABA: 16.31  6.20%; 10 mM
GABA:  4.65  6.70%; n  7,5; unpaired t test, p  0.047;
data not shown). No difference in potentiation was seen be-
tween puff applications of 200 M and 1 mM GABA (n  1, 7;
data not shown). Together with the effect of ascorbic acid on
standing leak current, these results demonstrate that endoge-
nous GABAC receptor function is strongly modulated by
ascorbic acid.
Responses mediated by homomeric 1 GABAC receptors are
enhanced by ascorbic acid
To further characterize the actions of ascorbic acid on GABAC
receptors, we heterologously expressed recombinant GABAC
receptors in frog oocytes. GABA applications to oocytes expressing
homomeric 1 GABAC receptors induced large inward Cl

currents displaying all of the features of retinal GABAC receptor-
mediated responses. For example, they are bicuculline insensi-
tive, TPMPA and picrotoxin sensitive, non-desensitizing, and
display the same pharmacological profile for agonists (Kusama et
al., 1993; Woodward et al., 1993). In addition, this experimental
model allowed us to control more precisely the extracellular con-
centration of ascorbic acid and the GABA concentration sensed
by the GABAC receptors; thus, a more quantitative approach was
possible. Figure 4A shows GABA1 responses measured in nor-
mal frog Ringer
s solution (control, 0.3 M GABA) or immedi-
ately after the application of ascorbic acid to the recording
solution.Current amplitudewas significantly enhanced (160%) in
the presence of 3mM ascorbic acid. Similar effects were produced
by brief exposures of the oocytes to a lower concentration of
ascorbic acid (700M) during sustained GABA applications (0.3,
1, or 10 M) (Fig. 4B). Ascorbic acid actions were strongly de-
pendent on GABA concentration, and were very rapid, stable,
and completely reversible after washout (Fig. 4B). No use-
dependent effects were observed, and no changes in activation,
deactivation, or desensitization of the GABA1 responses were
detected during ascorbic acid applications (data not shown).
D–R curves for GABA were shifted to the left and slightly but
significantly increased in their maximal values in the presence of
ascorbic acid (Fig. 5A, Table 1). Figure 5B illustrates the effects of
increasing concentrations of ascorbic acid on GABA1 responses
elicited by 0.3 and 1 M GABA. Maximal values of potentiation
obtained during applications of high concentrations of ascorbic
acid (30mM) were substantial (750%) (Fig. 5C). No significant
differences were observed in either the degree of potentiation at
different membrane potentials (reflected by the change in I–V
curves slopes) or in the reversal potentials of Cl currents in the
presence of ascorbic acid (Fig. 5D). The fast onset, fast offset, and
reversible character of ascorbic acid effects on GABAC receptors
all suggest that these effects are not due to its entry into the cells.
Based on this evidence, an extracellular superficial site of action is
more likely. This is in agreement with the fact that short (0–10 s)
or persistent (up to 30 min) applications of ascorbic acid pro-
duced identical results in oocytes expressing GABA1 receptors
(data not shown), and with data reporting that oocytes do not
express ascorbic acid transporters (SCVT1 and SCVT2) (Dyer et
al., 1994). I–V curves showing that modulation is independent of
themembrane potential also indicate regulatory sites located out-
side of the channel pore.
The specificity of ascorbic acid actions on GABA1 responses
was analyzed by testing structurally related analogs (Fig. 6A).
DHA (3mM) andCa(Asc)2 (1.5mM), two forms of ascorbate that
lack antioxidizing activity, were unable to produce changes in
currents elicited by 0.3 M GABA (Fig. 6B, Table 2). In contrast,
the stereoisomer D-iso-Asc (3 mM), which shows the same anti-
oxidizing power as ascorbic acid (Organisciak et al., 1992), had a
much lower efficacy (Fig. 6B, Table 2), indicating that structural
determinants are also essential for modulation. Kinetic analyses
of the GABA1 responses elicited by 0.3 M GABA, recorded in
normal frog Ringer
s solution or in the presence of ascorbic acid,
Ca(Asc)2, DHA, or D-iso-Asc showed time courses of activation
(act) and deactivation (deact) well fitted to single exponential
functions. No kinetic changes were observed in the presence of 3
mM ascorbic acid, 1.5 mM Ca(Asc)2, 3 mM DHA, or 3 mM D-iso-
Asc (Table 2). Desensitization values were negligible, thus deact
was not included for analysis.
Figure 3. Response to puffing GABA directly onto axotomized Mb bipolar cell presynaptic
terminals is enhanced by bath application of ascorbic acid.A, Puff application of 1mMGABA (25
ms duration, indicated by black bar) directly onto an axotomized Mb bipolar cell presynaptic
terminal in the presence of 25M SR-95531 produced (upper) a large GABAC-mediated inward
current (black trace). Bath application of 3mM ascorbic acid (red trace) increased the amplitude
of this current in a reversible manner (washout; blue trace). Each trace is the average of three
successive stimulations with an intertrace interval of 20 s. Summary data (bottom; n 8)
showeda significant and reversible increase inpuff response amplitude causedby3mMascorbic
acid. Mean for all cells with SE is shown in green (circles); data from each single cell (“x”) are
connected by gray dashed line, control data points (0 mM Asc) are shown in black, 3 mM Asc
points are shown in red, wash (0 mM Asc) points are shown in blue. B, Rundown normalization
of GABAC currents from cell inA, calculated using themean time after initial GABA puff, and the
linear rundown regressions from Figure 2B, showpotentiation of nearly 25% in the presence of
3 mM ascorbic acid, with a nearly complete washout in 0 mM Asc (top). Summary of corrected
data (bottom; n 8) showed a significant increase in puff response amplitude caused by bath
application of 3 mM ascorbic acid. Individual repeated-measures data are shown in gray (filled
circles), and mean values are shown in black (“x”; bottom). *p	 0.05; **p	 0.01; n.s., p
0.05; all statistical tests reflect a repeated-measures design; all errors are expressed asSE,
unless otherwise noted.
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Involvement of cysteines forming the Cys-loop and histidine
141 in the modulation of GABA1 receptors by ascorbic acid
We studied whether ascorbic acid effects on GABA1 responses
could be due entirely or in part to a direct interaction of this agent
with specific aminoacidic residues at the receptor subunits. Pre-
vious studies have suggested that cysteine residues are commonly
involved in the redox modulation of various ion channels (Ruiz-
G´omez et al., 1991; Ruppersberg et al., 1991; Sullivan et al., 1994;
Lipton et al., 2002; Chu et al., 2006). GABAC receptor 1 subunits
carry only two cysteines (C177 and C191) at the extracellular
domain forming the characteristic Cys-loop. Mutations of these
cysteines are precluded because they render receptors nonfunc-
tional (Amin et al., 1994; Sedelnikova et al., 2005). Thus, to de-
termine whether C177 and C191 are involved in the modulation
of the homomeric 1 GABAC receptors by ascorbic acid, we used
the irreversible thiol alkylating agent
N-ethylmaleimide (NEM), which forms
covalent bonds with the free sulfhydryl
groups preventing any further chemical
reaction at these sites. NEM concentra-
tion was kept as low as possible, and incu-
bation periods were kept very short to
prevent nonspecific effects. As shown in
Figure 7A, NEM alone produced, on
GABA1 receptors expressed in oocytes,
effects similar to those observed for ascor-
bic acid (Fig. 5A). D–R curves for GABA
afterNEM(30M) treatmentwere shifted
to the left, and their maximal values were
significantly increased. As expected for a
specific sulfhydryl reagent, NEM com-
pletely abolished dithiothreitol (DTT; 2
mM) potentiation of the GABA1 re-
sponses (Fig. 7B). Next, we studied the ac-
tions of ascorbic acid on GABA1 receptors previously treated
with 30MNEM.D–R curves showed that the increase produced
by 3mM ascorbic acid in GABA1 maximal responses (evidenced
in Fig. 5A) was entirely prevented after NEM treatment, whereas
the leftward shift was partially resistant to NEM (Fig. 7C). These
results indicate that the extracellular cysteines forming the Cys-
loop of the 1 subunits are involved in themodulation of GABAC
receptors by ascorbic acid. Effects of ascorbic acid may also be
partially due to redox modulation of C177 and C191, so addi-
tional mechanisms may also be involved.
Previous studies have demonstrated that H141, located near
the 1 subunit extracellular Cys-loop, is essential for allosteric
modulation of homomeric GABA1 receptors (Wang et al., 1995;
Zhang et al., 2001; Sedelnikova et al., 2005). Thus, we used site-
directed mutagenesis to study whether this amino acid residue
can also participate in the modulation of GABA1 receptors by
ascorbic acid.H141was replacedwith an aspartic acid to generate
mutant homomeric GABA1H141D receptors. When expressed in
oocytes, these receptors had typical responses to GABA (bicucul-
line insensitive and TPMPA sensitive) and showed EC50 values
for GABA slightly higher than wild-type receptors (Fig. 7D)
(Wang et al., 1995). The effects of ascorbic acid on mutant
GABA1H141D receptors were analyzed in D–R curves. Similarly
to wild-type receptors, maximal responses to GABA were signif-
icantly increased in the presence of 3 mM ascorbic acid (Fig. 7E).
However, the shift to the left produced by ascorbic acid on D–R
curves performed on wild-type GABA1 receptors (Fig. 5A) was
completely abolished in receptors carrying the mutation H141D
(Fig. 7E). In addition, ascorbic acid remained capable of poten-
tiating responses evoked by low GABA concentrations (Fig. 7E,
inset). We also analyzed the specific contribution of C177 and
C191 to the effects induced by ascorbic acid on GABA1H141D
receptors in oocytes previously treated with NEM. Ascorbic acid-
induced increases in maximal responses evoked by GABA on
wild-type receptors was completely prevented by NEM treat-
ment, but potentiating effects of ascorbic acid on GABA1 re-
sponses induced by low GABA concentrations on the mutant
GABA1H141D receptors remained unaltered (Fig. 7F, inset).
Ascorbic acid might exert pro-oxidant effects onmembrane pro-
teins through a selective metal-catalyzed oxidation involving the
modification of histidines (Stadtman, 1991, 1993; Nelson et al.,
2007). However, this possibility was dismissed because ascorbic
acid effects on GABA1 responses were identical in the presence
of themetal-chelating agents EDTAand tricine (data not shown).
Figure 4. Homomeric 1 GABAC receptor function is enhanced by ascorbic acid. Representative traces of ionic (Cl
) currents
elicited by different GABA concentrations in oocytes expressing homomeric GABA1 receptors. Calibration: current amplitude
( y-axis), time (x-axis). For this and the subsequent figures, oocytes were voltage-clamped at70 mV. A, GABA1 responses
recorded before (left, control) and after the application of 3mM ascorbic acid (right). Potentiation of GABA1 responses by ascorbic
acid was 162 22.6% (n 3). B, Ionic currents elicited by increasing concentrations of GABA (0.3, 1, and 10 M) were also
enhanced during concurrent applications of 700M ascorbic acid.
Figure 5. Analysis of ascorbic acid effects on GABA1 receptor function. A, D–R curves
for GABA performed in the presence or absence of ascorbic acid. Response amplitudes
were expressed as a fraction of maximal GABA-evoked currents (30 M GABA). B, Dose–
effects curves for ascorbic acid acting on GABA1 responses. Data were normalized to
control values, obtained in the absence of ascorbic acid, for two different GABA concen-
trations. All the points tested 100 M were significantly different from control. C,
Degree of potentiation of the GABA1 responses by ascorbic acid for increasing concen-
trations of GABA. D, I–V relationships of the GABA1 responses measured in the presence
or absence of ascorbic acid.
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In addition, several oxidizing agents antagonize GABA1 re-
sponses (Calero and Calvo, 2008), and Zn2 interaction with
H141 also causes a reversible inhibition (Wang et al., 1995). In
contrast, we found that H141 is critically involved in potenti-
ation of GABA1 receptor function by ascorbic acid. A proton
transfer from ascorbic acid to H141 was also disregarded be-
cause pH (7.4) was constant during experiments. Moreover,
critical residues for pH sensitivity are located within the first
60 N-terminal amino acids in 1 subunits (Rivera et al., 2000).
Thus, H141 would be involved in an independent conforma-
tional change, allosterically induced by ascorbic acid at or near
the Cys-loop of GABA1 receptors, which might take place
simultaneously with redox modification of C177 and C191 at
1 subunits. All of these events would occur near the extracel-
lular agonist-binding site.
Modulation of neuronal and
recombinant GABAA receptors by
ascorbic acid
Based on our findings, we decided to test
whether ascorbic acid could produce sim-
ilar effects on GABAA receptors. Whole-
cell patch-clamp recordings were
performed on both presynaptic terminals
of retinal bipolar cells and transfected cells
expressing two types of recombinant
GABAA receptors. Figure 8A shows an ex-
ample recording demonstrating a revers-
ible increase in the amplitude of
miniature GABAA receptor-mediated IP-
SCs (i.e., mIPSCs) following extracellular
application of 3 mM ascorbic acid. The
mean mIPSC waveforms for this example
recording (Fig. 8B, left) show a distinct,
reversible increase in mIPSC amplitude.
This effect can also be seen as a reversible
rightward shift in the cumulative probability curve for mIPSC
amplitude (same example cell) following addition of ascorbic
acid (Fig. 8B, right). Although ascorbic acid appeared to increase
mIPSC frequency (2.44 Hz control vs 5.34 Hz Asc) and preferen-
tially affect larger mIPSCs (12 pA) in this example cell (Fig. 8B,
right), there was no overall significant effect of ascorbic acid on
mIPSC frequency [control (0 mM Asc) 3.01 1.26 Hz; 3 mM
Asc  3.80  1.45 Hz; wash (0 mM Asc)  3.58  1.39 Hz;
repeated-measures ANOVA, n 5, p 0.28] (Fig. 8C, right). It is
possible that in some cells, ascorbic acid potentiation of mIPSCs
raised their amplitude above our detection threshold and thus
caused an apparent increase in the frequency of small mIPSCs.
However, examination of the mIPSC amplitude distribution
(Fig. 8B, right) showed a clear shift in cumulative probability
over the whole range of amplitudes, indicating that the effect of
ascorbic acid was not specific for a small subset of mIPSCs (Fig.
8C, right). In fact, both the enhancement of mIPSC amplitude by
bath application of 3 mM ascorbic acid, and the reversibility of
this effect upon washout, were statistically significant [control (0
mM Asc) 15.42 2.51 pA; 3 mM Asc 18.45 3.23 pA; wash
(0mMAsc) 15.62 2.48 pA; repeated-measures ANOVA, n
5, p 0.014; Tukey’smultiple comparison test, control (0mM) vs
3mMAsc, p	 0.05; 3mMAsc vs wash (0mMAsc), p	 0.05] (Fig.
8C, left). These results show that ascorbic acid potentiation is
effective at local GABA concentrations in the synaptic cleft seen
under physiological conditions.
Native and recombinant GABAA receptors can be modulated
by a number of redox agents whose effects depend on receptor
subunit composition. In particular, the presence of the2 subunit
was shown to reduce the sensitivity of GABAA receptors to exog-
enous and naturally occurring redox reagents (Amato et al., 1999;
Pan et al., 2000). Thus, redoxmodulation at GABAergic synapses
is predicted to vary throughout the CNS, depending on the
GABAA receptor subtypes expressed. To examine the ascorbic
acid sensitivity of GABAA receptors with known subunit compo-
sitions, two combinations of recombinantGABAA receptorswere
transfected in HEK cells, namely, 122 and 12 receptors. In
fact, expression of 1, 2, 3, 1, 2, 3, 2, and  subunits has
been previously reported in retinal neurons (Wa¨ssle et al., 1998;
Koulen, 1999; Zhang et al., 2003). GABAA receptor-mediated
inward currents recorded in HEK cells at 60 mV were signifi-
cantly enhanced by extracellular application of ascorbic acid over
the entire range of concentrations tested (0.5–10mM). Responses
Figure 6. Effects of different ascorbic acid analogs on GABA1 receptor function. A, Chemical structures of the diverse com-
pounds used. B, Histogram summarizing the values obtained for GABA1 responses evoked by 0.3 M GABA recorded before
(control, dotted line) and after exposure to the different ascorbic acid analogs (n 4).
Table 1. Dose-response curve parameters
EC50 (M) n (Hill coefficient) n
Control 0.74 0.01 1.58 0.04 5–10
3 mM Asc 0.49 0.01* 1.88 0.07 5–10
Control 1.52 0.04 2.24 0.05 4
30M NEM 1.29 0.02 2.24 0.10 4
30M NEM 3 mM Asc 0.75 0.01 2.44 0.19 4
Control 0.86 0.10 2.58 0.30 3
30M NEM 0.78 0.09 2.32 0.10 3
30M NEM 2 mM DTT 0.74 0.06 2.04 0.08 3
H141D 1.76 0.21 3.41 0.61 10
H141D 3 mM Asc 2.07 0.32 2.94 0.38 5
H141D 30M NEM 1.40 0.16 3.24 0.16 4
H141D 30M NEM 3 mM Asc 1.46 0.24 3.48 0.28 4
Parameters of the D–R curves for GABA, performed for GABA1 wt and GABA1 H141D in the absence or presence
of the different agents. *p	 0.03.
Table 2. Effects of ascorbic acid and its analogs on GABA1 responses
Compound % Potentiation n act (s) deact (s) n
Control (GABA 0.3M) 6 24.8 1.6 23.5 3.8 6
3 mM Asc 139.5 87.5** 7 22.6 2.6 28.1 3.3 6
3 mM D-isoAsc 33.5 12.5* 4 28.5 2.5 33.4 1.9 6
3 mM DHA 1.6 4.2 3 26.1 2.8 32.0 2.8 6
1.5 mM Asc(Ca)2 7.4 4.8 6 22.5 2.5 27.4 4.3 4
Potentiation (%) produced by ascorbic acid and its different analogs on GABA1 responses and values obtained for
kinetic parameters in the presence of the different compounds. *p	 0.04, **p	 0.01.
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mediated by GABAA receptors lacking the 2 subunit were
strongly potentiated by ascorbic acid (up to a600% by 10mM),
whereas responses mediated by 122 receptors were also effec-
tively increased by ascorbic acid, but to a lesser extent (up to
200% by 10 mM). Data were summarized in Figure 9. These
results indicate that ascorbic acid can produce on GABAA recep-
tors effects similar to those exerted by other redox agents, and
that GABAA receptor subtypes show a differential sensitivity to
ascorbic acid modulation.
Discussion
We have shown a remarkably potent modulation of retinal and
heterologous GABAC and GABAA receptors by physiologically
relevant concentrations of ascorbic acid. Surprisingly, we believe
that the present findings are the first to demonstrate that this
ubiquitous and endogenous redox agent can regulate the func-
tion of Cys-loop receptors.
Effects of ascorbic acid on GABAC receptors
The potentiating effects of ascorbic acid on native and recombi-
nant GABAC receptors were similar to those shown by many
reducing agents acting on different ionotropic GABA receptors
and other Cys-loop receptors (Bouzat et al., 1991; Ruiz-Go´mez et
al., 1991; Pan et al., 1995, 2000; Amato et al., 1999; Calero and
Calvo, 2008). Efficacy of ascorbic acid on retinal GABAC re-
sponses appears to be relatively lower than on responses medi-
ated by GABA1 receptors, probably because experiments in the
retina required higher concentrations of GABA to counteract the
action of GABA transporters and extracellular diffusion. Addi-
tionally, differences may be due to variations in the sensitivity to
ascorbic acid among receptors from different species (fish vs hu-
man), the possible existence of heteromeric receptors in the ret-
ina (e.g., GABAC receptors containing 2 or 3 subunits), the
interaction of native receptors with accessory subunits or regula-
Figure 7. Identification of amino acid residues involved in themodulation of homomeric1
GABAC receptors by ascorbic acid. A, The irreversible methylation of C177 and C191 at the
Cys-loop, by pretreatment of oocyteswith 30MNEM, produced similar effects to those shown
by ascorbic acid on D–R curves for GABA. B, NEM pretreatment completely abolished the po-
tentiation of GABA1 responses induced by 2mMDTT. C, NEMpretreatment partially prevented
the potentiation of GABA1 responses by 3mMascorbic acid.D, D–R curves for GABAperformed
on wild-type GABA1 and mutant GABA1H141D receptors. E, Mutation of H141 to D at the 1
subunit partially prevented the potentiating actions of ascorbic acid. Effects of 3 mM ascorbic
acid on D–R curves for GABA were performed on GABA1H141D receptors. Ascorbic acid signifi-
cantly enhanced maximal responses and currents evoked by very low GABA concentrations
(inset), but failed to induce a leftward shift in the D–R curve (as that observed in C), indicating
that theH141 is critical for ascorbic acidmodulatory actions.F, NEMpretreatment abolished the
potentiation induced by ascorbic acid on maximal responses mediated by GABA1H141D recep-
tors, indicating that they are more likely mediated by C177 and C191, but effects at very low
GABA concentrationswere not prevented byNEM (inset). Response amplitudeswere expressed
as a fraction of the 30MGABA-evoked currents (maximal response). Each point represents the
mean and SEM of the responses obtained from four to six oocytes. Notice that many of the SE
bars are hidden by the symbols.
Figure 8. The amplitude of GABAA mIPSCs is enhanced by bath application of ascorbic acid.
A, Excerpts (1.3 s each) from continuous records of mIPSCs from a single axotomized Mb1
terminal (at least 120 s per condition) in the presence of 150M TPMPA (GABAC antagonist), 10
M NBQX, 50M DL-APV, and 1M TTX show that 3 mM ascorbic acid reversibly increased the
amplitude of GABAA mIPSCs without significantly increasing mIPSC frequency. B, The ampli-
tude of themean IPSCwaveformofGABAAmIPSCswas reversibly enhancedbynearly 30%(left)
following bath application of 3 mM ascorbic acid (same cell as in A). The mIPSC amplitude
cumulative probability distribution (bin 1 pA) for control (0 mM Asc, count 353), 3 mM
ascorbic acid (count 770), and wash (0 mM Asc, count 574) conditions (right) showed a
distinct, reversible rightward shift (larger amplitudes) in cumulative probability in the presence
of 3 mM ascorbic acid. C, Summary of data for all cells (n 5) shows a significant, reversible
increase in GABAAmIPSC amplitude (left),with no significant effect onmIPSC frequency (right),
following bath application of 3 mM ascorbic acid. Mean for all cells with SE shown in green
(circles), data from each single cell (“x”) connected by gray dashed line, control data points (0
mMAsc) shown in black, 3mMAsc shown in red,wash (0mMAsc) shown in blue. *p	 0.05; n.s,
p 0.05; all statistical tests reflect a repeated-measures design; all errors are expressed as
SE, unless otherwise noted.
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tory proteins not present in oocytes, or endogenous redox buffers
that could be absent or altered in heterologous systems.
Mechanisms underlying the modulation of GABAC receptors
by ascorbic acid
We showed that the Cys-loop residues C177 and C191, along
with H141, all located near the extracellular agonist-binding site,
take part in themodulation of GABAC receptors by ascorbic acid.
The shift to the left produced by ascorbic acid on the GABA1
receptorD–R curve (Fig. 5A) can be explained by a decrease in the
energy barrier for GABA activation induced by this agent. Ascor-
bic acid could bind to or modify one or more sites capable of
allosterically modulating single-channel properties, for example,
by inducing an increase in GABA affinity that involves H141. In
addition, to describe the simultaneous increase observed in the
maximal response, which is more likely mediated by a redox
modification of C177 and C191, a possibility is that ascorbic acid
acts to favor the conversion from the last GABA-bound closed
state to the open state (Goutman et al., 2005). Alternatively,
ascorbic acid could induce the channels to transition toward ad-
ditional open states in which the receptor adopts lower energy
conformations with higher open probabilities. We found that
GABA1 channel deactivation fromopen states was not altered in
the presence of ascorbic acid (Table 2), which suggests that the
first alternative is more likely. However, a combination of differ-
ent mechanisms could also occur. Further analysis, including
binding experiments, single-channel recording, and kinetic stud-
ies, is necessary to address these questions.
We also showed that the intracellular application of ascorbic
acid prevents rundown of GABAC receptor-mediated inward
currents at the Mb presynaptic terminals. There are many intra-
cellular targets of redox modulation, and mitigation of general
oxidative stress is likely to also prolong the viability of a cell
following dialyzation by the patch pipette. Rundown of GABAC
currents during the course of a 15–20min patch-clamp recording
has been shown to depend on PKC phosphorylation and to be
inhibited by addition of phosphatases to the intracellular solu-
tion (Feigenspan and Bormann, 1994). Thus, a candidate could
be the potential interaction of ascorbic acid at these signaling
pathways. Interestingly, recent studies showed that the genera-
tion of reactive oxygen species (ROS) can induce rundown of
currentsmediated by neuronal acetylcholine receptors (nAChRs)
(Campanucci et al., 2010). This rundown is triggered by ROS-
induced oxidation of C239, an intracellular cysteine residue con-
served in many nAChR subunits (e.g: 3, 4, 2, and 4) that
forms a ring located at theM1-M2 linker near the innermouth of
the channel pore. Based on these data, and on the fact that 
subunits in GABAC receptors also carry an intracellular cysteine
(C364) at the M3-M4 linker, the prevention of GABAC current
rundown exerted by ascorbic acidmight act as a protectivemech-
anism against ROS actions.
Effects of ascorbic acid on GABAA receptors
Redox modulation of GABAA receptors has been demonstrated
in heterologous systems and in different areas of theCNS, includ-
ing the retina (Pan et al., 1995; Amato et al., 1999). GABAA re-
ceptors from retinal ganglion cells are significantly inhibited by
oxidants and are potentiated by reducing agents (Pan et al.,
1995), but studies in retinal bipolar cells were lacking. We show
thatGABAA receptors located on the presynaptic terminals ofMb
bipolar cells, which likely contain the 2 subunit (Wa¨ssle et al.,
1998), can be modulated by ascorbic acid. This is a significant
finding, because it directly shows that ascorbic acid can potenti-
ate synaptic GABAA-mediated currents in intact retinal tissue.
Additionally, experiments performed on recombinant 122
and 12 GABAA receptors showed that ascorbic acid actions
depend on subunit composition. GABAA receptors containing
the2 subunit had a decreased sensitivity to ascorbic acid (Fig. 9),
in agreement with the reduced sensitivity to redox agents exhib-
ited by hippocampal, cerebellar, and ganglionicGABAA receptors
(Amato et al., 1999).
Potential physiological relevance of the modulation of
GABAC receptors by ascorbic acid
Ascorbic acid is highly concentrated in the retina, both in extra-
cellular (200–500 M) and intracellular (10 mM) compart-
Figure 9. Potentiation of the12 and122 GABAA receptor function by ascorbic acid.
A, Representative traces of ionic (Cl) currents mediated by12 and122 GABAA recep-
tors expressed in HEK cells. Inward GABAA currents were elicited by bath applications of 1 or 5
M GABA (the corresponding EC50 values for GABA showed by 12 and 122 GABAA
receptors, respectively) and recorded by whole-cell voltage-clamp at 60 mV. GABAA re-
sponsesmediated by both12 and122 GABAA receptors were significantly enhanced in
the presence of 0.5 and 1 mM ascorbic acid. B, Dose– effect curves for ascorbic acid actions on
12 and 122 GABAA receptors (n  3; curves performed at the corresponding EC50
values). Data were normalized to control values, obtained in the absence of ascorbic acid.
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ments (Rose and Bode, 1991; Rice, 2000; Castro et al., 2001;
Hediger, 2002; Hosoya et al., 2004). During and after neuronal
activity, local levels of ascorbic acid surrounding retinal bipolar
neurons can reach millimolar values due to SVCT2-mediated
sodium-dependent extrusion (Portugal et al., 2009). GABA1 re-
ceptor potentiation by ascorbic acid can be significant at extra-
cellular concentrations as low as 0.3 mM, with effects becoming
substantial at0.7 mM (Fig. 4B). Meanwhile, the activity of ret-
inal GABAC receptors was considerably increased by extracellular
ascorbic acid in the low-millimolar range (3 mM) (Figs. 1, 2).
Ascorbic acid effects on GABAC receptors strongly depended on
GABA concentration. As GABAC receptors show relatively high
affinity for GABA (compared with GABAA receptors), ascorbic
acid modulation at low GABA concentrations could be ideally
located within the dynamic range of ion channel activation. If
so, the regulation of retinal GABAC receptors would be highly
dependent on local ascorbic acid release and instantaneous extra-
cellular GABA concentration. In particular, extrasynaptic recep-
tors, which would presumably see lower concentrations of
GABA, might be more powerfully modulated by ascorbic acid.
Tonic inhibition provides a constant shunt to the Mb termi-
nal, which likely acts to prevent release in the absence of strong,
high-frequency inputs, and activation of the standing leak cur-
rent is closely controlled by the GABA transporter GAT1 (Hull et
al., 2006). Reciprocal inhibition, which occurs when release of
glutamate from the Mb terminal triggers direct GABA feedback
from local amacrine cell presynaptic boutons, is comprised of a
fast GABAA component and a slow, sustained GABAC compo-
nent (Vigh and von Gersdorff, 2005). Reciprocal inhibition di-
rectly controls the duration and intensity of glutamate release
from the Mb terminal. Finally, lateral inhibition, elicited when
stimulation of a parallel bipolar cell pathway triggers unidirec-
tional GABA release from a local amacrine cell bouton onto both
GABAA and GABAC receptors on the Mb terminal, may act to
shape the offset of bipolar cell light responses (Cha´vez et al.,
2010). Strong modulation of tonic, reciprocal, and lateral inhibi-
tion at Mb terminals by ascorbic acid is likely to shape ganglion
cell responses via control of glutamate release. However, given
the previously described effects of ascorbic acid on T-type Ca2
channels (Nelson et al., 2007) and K channels (Fan and Yazulla,
1999), mechanisms of modulation of retinal physiological re-
sponses by this agent might be more complex.
We showed here that ascorbic acid enhanced standing leak
currents and responses activated by local GABA puffs in the pres-
ence of gabazine, both of which are mediated by GABAC recep-
tors at the presynaptic terminals of retinal Mb bipolar cells. This
suggests that ascorbic acid modulation can occur during either
acute (similar to reciprocal or lateral synaptic inhibition), sus-
tained (tonic standing leak current), or strong (under conditions
of a high rate of GABA release) activation of GABAC receptors.
Additionally, ascorbic acid could be involved in a “negative feed-
back” phenomenon following strong bipolar cell depolarization.
This depolarization would cause strong glutamate release, which
in turn would stimulate release of ascorbic acid into the extracel-
lular space (Portugal et al., 2009). Increased concentrations of
extracellular ascorbic acid can potentiate GABAC- and GABAA-
mediated currents, enhancing local inhibition. In this context,
ascorbic acid effects on both GABAA and GABAC responses
would be consistent with the effects of glutamate on SVCT2-
mediated ascorbic acid extrusion. Unfortunately, the subcellular
localization of SVCT2 in neurons or glial cells still is unknown
(Castro et al., 2001; Harrison and May, 2009). In conclusion,
although the precise physiological role that ascorbate plays in the
regulation of GABAergic neurotransmission needs to be further
investigated, our results clearly indicate that ascorbic acid can act
as an important endogenous modulator of ionotropic GABAC
and GABAA receptors in the retina and probably also in other
areas of the CNS.
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